Market Performance
- Apollo Hospitals’ share price surged as much as 4% to ₹7,555 on July 1, 2025, during intraday trading.
- At 9:20 am, the stock was trading at ₹7,492, up 3% on the NSE.
- Over the past three months, the share price has increased by 10%.
Main News: Board Clears Demerger of Digital & Pharmacy Business
Apollo Hospitals Enterprises announced a significant corporate restructuring move on July 1. The company’s board, along with its subsidiary Apollo HealthCo, gave in-principle approval for a composite scheme of arrangement.
Key Highlights:
- Apollo will demerge its omnichannel pharmacy and digital health operations.
- The operations include its telehealth vertical and investment in Apollo HealthCo Ltd (AHL).
- These units will be carved out into a new entity (NewCo).
- Apollo HealthCo Ltd (AHL) will be merged into NewCo following the demerger.
Company Details: A New Healthcare Giant in the Making
The proposed restructuring will create a large-scale integrated pharmacy and digital healthcare platform in India.
What’s Included in the New Entity (NewCo):
- Apollo HealthCo Ltd (AHL)
- Omni-channel pharmacy and telehealth operations
- Keimed Pvt Ltd, one of India’s largest pharma wholesalers
- Apollo Medicals Pvt Ltd (AMPL), with NewCo acquiring the remaining 74.5% stake
- Apollo Pharmacies Ltd (APL), a 100% subsidiary of AMPL
This move consolidates control of the front-end pharmacy business under NewCo.
Notable Facts:
- NewCo will be classified as an Indian Owned and Controlled Company (IOCC).
- The company aims to secure a listing on Indian stock exchanges within 18–21 months, pending regulatory approval.
- Apollo Hospitals Enterprise Ltd (AHEL) will retain a 15% stake in NewCo to ensure seamless integration with its healthcare ecosystem.
Revenue & Growth Outlook (As Stated by Company)
- Target Revenue for NewCo by FY27: ₹25,000 Crore
- Distribution Model:
- 7,000+ physical pharmacy outlets
- Digital platform coverage across 19,000 pincodes
Summary of the Article
- Apollo Hospitals’ share price rose sharply following the company’s announcement of a major business restructuring.
- The board has cleared a plan to demerge and list its pharmacy and digital health verticals under a new entity, integrating Apollo HealthCo and Keimed Pvt Ltd.
- This new structure is intended to unlock value and streamline operations, with Apollo retaining a strategic stake to ensure ecosystem continuity.
- The company targets a ₹25,000 Crore revenue milestone for NewCo by FY27 and aims to enhance healthcare delivery across India through a powerful omni-channel presence..
